Research at PFC
* There are no current open studies at PFC. Please check back again for any changes. *
contact our New Patient Coordinators to make an appointment to speak with one of our physicians. 415-834-3095. Our Active Studies include the following:
A RANDOMIZED, CONTROLLED CLINICAL TRIAL OF THE EFFECT OF TRADITIONAL CHINESE MEDICINE ON IVF SUCCESS RATES
Who Is Sponsoring This Study? The study is Sponsored by Pacific Fertility Center and is overseen by Eldon Schriock, M.D. Grant support providing medications and funding for study development has been provided by EMD Serono, a biopharmaceutical company. What is the Purpose of This Study? The purpose of this study is to determine the value of combining Traditional Chinese Medicine (TCM) Protocols including acupuncture with In Vitro Fertilization (IVF).
The Auxogyn Eeva Study
Who Is Doing The Study? Auxogyn, Inc. has selected Pacific Fertility Center as one of several centers to participate in The Auxogyn Eeva Study Why Are We Doing This Study Auxogyn is initiating a clinical study in an effort to submit data to the FDA to support the claim that the Eeva System may be used to identify embryos at day 2 that are most likely to form blastocysts. As a result, the Eeva System Study is an investigational study and is a non-significant risk device. How Data Will Be Used The data collected in this study are intended to demonstrate the effectiveness of the Eeva System to successfully capture and record images of embryo development within a standard incubator and accurately identify those embryos on day 2 that are most likely to form blastocysts. The results may lead to effective methods for embryologists to identify the most viable embryos so that embryo implantation and pregnancy outcome may be significantly improved for future IVF patients. A higher success rate such as that seen with blastocyst transfer may be achieved for day 2 embryo transfer by using the Eeva System to select embryos; therefore, the adverse events associated with extended culture may be avoided. It may also facilitate implementation of single embryo transfer on cleavage stage (day 2 or day 3) and reduce multiple pregnancies. In summary, this new technology may increase IVF success rates within a given cycle and improve pregnancy and birth outcomes.
Impact of Parental Support on Pregnancy Outcomes (IPSO) Trial- Day 3 Preimplantation Genetic Screening (PGS) With Day 5 Fresh Transfer
Who Is Doing The Study? Gene Security Network (GSN) has selected Pacific Fertility Center as one of several centers to participate in The IPSO Trial Why Are We Doing This Study? The purpose of the study is to determine whether PGS - testing of embryos created during IVF for chromosome abnormalities prior to transfer to the uterus - improves pregnancy and implantation rates in patients when compared to patients whose embryos are not tested. PGS will be conducted using 24 Chromosome Aneuploidy Screening with Parental Support from Gene Security Network